183490 — Enzychem Lifesciences Income Statement
0.000.00%
Last trade - 00:00- KR₩91bn
- -KR₩20bn
- KR₩77bn
- 37
- 40
- 31
- 26
Annual income statement for Enzychem Lifesciences, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2020 December 31st | R2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 25,818 | 22,975 | 26,638 | 76,039 | 77,378 |
| Cost of Revenue | |||||
| Gross Profit | 1,820 | 287 | 2,416 | 4,348 | 4,310 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 45,445 | 44,147 | 45,999 | 90,428 | 91,441 |
| Operating Profit | -19,626 | -21,172 | -19,361 | -14,389 | -14,064 |
| Gain / Loss on Sale of Assets | |||||
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -19,232 | -29,504 | -25,581 | -9,879 | -22,084 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -17,507 | -27,865 | -25,093 | -9,403 | -22,088 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Net Income | -17,507 | -27,865 | -25,093 | -9,326 | -22,107 |
| Adjustments to Net Income | |||||
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -17,443 | -26,923 | -24,934 | -9,326 | -22,107 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -276 | -528 | -278 | -109 | -263 |
| Dividends per Share |